Compugen to Present at Jefferies 2015 Global Healthcare Conference in London
November 12 2015 - 6:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug
discovery company, today announced that Dr. Anat Cohen-Dayag,
President and Chief Executive Officer of Compugen, will present a
corporate overview and update at the Jefferies 2015 Global
Healthcare Conference in London, UK, on Wednesday, November 18,
2015.
About Compugen
Compugen is a leading drug discovery company utilizing its
broadly applicable predictive discovery infrastructure to identify
novel drug targets and develop first-in-class biologics. The
Company’s current pipeline primary focus is on immune checkpoint
target candidates discovered by the Company, potentially providing
the basis for a next wave of therapeutics for cancer immunotherapy.
Compugen’s business model is based on selectively entering into
collaborations for its novel targets and drug product candidates at
various stages of research and development under revenue-sharing
agreements. The Company is headquartered in Tel Aviv, Israel, with
R&D facilities in Tel Aviv and South San Francisco. At the US
facilities, monoclonal antibody therapeutic candidates are
discovered and developed against the Company’s novel target
candidates. For additional information, please visit Compugen's
corporate website at www.cgen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151112005550/en/
Compugen Ltd.Tsipi HaitovskyGlobal Media
Liaison+972-52-598-9892tsipih@cgen.com
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024